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Abbreviations 
 
22NaCl   sodium-22 radionuclide NaCl 
ATR   attenuated total reflectance 
AUC   area under the curve 
Bq   Becquerel 
Da   dalton 
DMARD  disease-modifying antirheumatic drugs 
DSC   differential scanning calorimetry 
EDTA   ethylenediaminetetraacetate 
FTIR   Fourier Transform Infrared 
FWHM  full width at half maximum 
G´   storage modulus of shear 
G´´   loss modulus of shear 
H2O   water 
HA   hyaluronic acid 
HPC   hydroxypropyl cellulose 
i.a.   intra-articular 
IgG   immunoglobulin G 
IL   interleukin 
IR   infrared 
MALS   multi-angle light scattering 
Mw   molecular weight 
NaHA   sodium hyaluronate 
NMR   nuclear magnetic resonance 
NSAID  non-steroidal antiinflammatory drugs 
NSARD  non-steroidal antirheumatic drugs 
o-Ps   orto-positronium 
PALS   positron annihilation lifetime spectroscopy 
PMMA  polymethyl methacrylate 
polyHEMA  poly-(2- hydroxyethyl)-methacrylate 
p-Ps   para-positronium 
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PVA   polyvinyl alcohol 
QbD   Quality by Design 
rpm   revolutions per minute 
SEC   size-exclusion chromatography 
SEC-MALS  size-exclusion chromatography multi-angle light scattering 
SEC-MALS-RI size-exclusion chromatography multi-angle light scattering and  
   refractive index 
SEM   scanning electron microscopy 
TBF-α   tumor necrosis factor alpha 
TG   thermogravimetric 
UV   ultraviolet 
XRPD   X-ray powder diffraction    
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1. Introduction 
 
One third of Europeans suffers at least once in their life from rheumatic diseases and 
furthermore all fifth people stands longer time under such treatment (Eular, 2011). By 
contrast, a disproportionately small number of products are marketed for intra-articular 
treatments. Several forms of rheumatic diseases are also known but only in a few cases 
there is the possibility of complete recovery or to prevent the disease. Besides surgical 
treatments nowadays a number of drugs are available for the systemic drug therapy. 
However, it is not significant in the joint injectable (intra-articular) forms of the locally 
applied active ingredients. The compositions of synovial fluid space are very similar to 
those of the serum and they are in constant contact with the bloodstream, but it is 
difficult to have a systemic drug therapy without unnecessarily high load of the 
organization (Gerwin et al., 2006). By using intra-articular applications drugs can be 
directly injected into the joint, which can ensure a high local drug concentration and low 
systemic effect. The non-invasive therapies are more comfortable drug delivery for the 
patients but in the long run the intra-articular therapy causes less damage to health such 
as digestive tract and renal vascular side effects (Edwards et al., 2007).  
 
1.1. Intra-articular delivery systems 
 
1.1.1. Anatomy of articular joint 
 
Human joint is one of the best units of the nature. Its role is to maintain stability 
and movement of the skeleton, accompanied by precise function through the life, even 
under extreme load capacity. However, the secret to this ongoing development of 
renewed bone is the cartilage and synovial fluid. For the joints function without friction 
an extremely smooth surface is required. This ensures the cartilage which is stably and 
elastically covers the bone. The synovial fluid as a lubricant protects the cartilage by 
supplying with nutriment and oxygen. The synovial fluid (synovia) is produced by the 
synovial membrane which covers the connective tissue in the joint capsule. The capsule 
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prevents the exit of the synovial fluid from the articular cavity. The joint is held 
together by the ligament (Figure 1) (Röder, 2010). 
 Sufficient oxygen and nutrients to absorb into the cartilage from the joint fluid it 
is essential to move. Thereby resulting pressure effect that from the cartilage depleted 
synovial fluid is pressed out and is replaced with fresh fluid. So the cast synovial fluid 
enters the bloodstream through the synovial membrane and fresh nutrients and oxygen 
from the blood comes into the synovial. 
 
 
Figure 1 Schematic illustration of healthy joint (Röder, 2010) 
 
 
 Intra-articular (i.a.) preparations go directly into the synovial fluid. Therefore it 
is important to know the exact composition of the synovial fluid (Table 1). The synovia 
is none other than the blood dialysate (Zeidler, 1986). The composition and content of 
electrolytes and low-molecular materials is identical to those of serum. In the healthy 
joint the synovial fluid amounts approximately 0.5-2 ml (Dewire et al., 2001; Mason et 
al., 1999). The synovial fluid is changed continuously and rapidly (approx. 2 hours) and 
one of the key components of the synovia is only renewed every 38 hours (Mason et al., 
1999).  
DOI:10.14753/SE.2016.1870
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Table 1 Composition of healthy synovial fluid (Zeidler, 1986) 
Physical data and materials Mean value Extreme 
range 
Physical data   
Volume (ml/normal knee joint) 1.1 0.13-4.0 
Relative density - 1.008-1.015 
Osmolarity (mmol/l) 296 292-300 
pH 7.434 7.31-7.64 
Water (g/kg) - 960-988 
Solids (g/kg) 34 12-48 
Cells (per µl) - 13-180 
Inorganic materials   
Carbon dioxide (mmol/l) - 19.3-30.6 
Chloride (g/l) 3.81 3.08-4.89 
Phosphate corresponds to the contents of the serum  
Potassium (mg/l) 156 - 
Sodium (g/l) 3.13 - 
Calcium (mg/l) - 48-96 
Iron (µg/kg) 290 - 
Copper (µg/kg) 275 - 
Zinc (µg/kg) 176 - 
Organic materials   
Glucose corresponds to the contents of the serum  
Urea (mg/l) 150 - 
Uric acid (mg/l) 39 - 
Total protein (g/l) 13.1 10.4-15.8 
Albumin (g/l) 8 6-10 
Globulin (g/l) 0.5 - 
Hyaluronic acid (g/l) 2.26 1.45-2.94 
Chondroitin sulfate (mg/l) 42 - 
Lipids :   
Cholesterol 71 - 
Phospholipids 138 130-152 
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 Basically, the hyaluronic acid (HA) is responsible for the viscoelasticity of the 
synovia (Balazs et al., 1970; Balazs, 2009). The result of the viscoelasticity is that in 
case of low-frequency movement of the joint the viscous liquid works as a lubricant and 
in case of major mechanical stress the viscous liquid can store mechanical energy 
elastically. In the inflamed joints larger quantities (up to 100 ml) of synovial fluid can 
be produced wherein the hyaluronic acid lose its viscosity by reduction of the 
concentration and the molecular weight (Marshall et al., 1997). The viscosity of the 
synovial fluid of a healthy joint exceeds 300 mPa × s. However, after the outbreak of 
rheumatic symptoms the viscosity drops below 300 mPa × s (Dewier et al., 2001, 
Simkin, 1985). 
 
1.1.2. Rheumatic diseases 
 
Rheumatic diseases can be arthrosis (wear of joint) or arthritis (inflammation of 
joint). 
 Arthrosis, osteoarthrosis and degenerated articular rheumatism class in articular 
wear diseases (Röder, 2010). Presumably, arthritis is caused by the imbalance between 
the demand and supply of nutrients. Other possible reasons are that the synovial fluid 
gets only a few nutrients or because of the lack of movement an inadequate nutrient 
circulation arises. If the cartilage does not get the proper quantity of nutrients from the 
joint fluid, cartilage cells die. The results are that the cartilage is torn into fibers and 
loses from the smooth surface. With any further movement a piece of cartilage drops 
out and the bone protected membrane becomes thinner (Figure 2) (Röder, 2010). The 
bone forms bulges below the cartilage which cause the breaking off further pieces of 
cartilage. The immune system treats these pieces in the synovial fluid as a foreign body 
which so the inflammation caused triggers a protective reaction. As a result, materials 
having a disastrous effect on cartilage are sent out which leads to rapid death of the 
cartilage cells. Because of the pain from inflammation patients move even less which 
leads to even less nutrient emissions. The resulting circulus vitiosus is difficult to curb. 
Arthrosis affects most often the load bearing joints such as the hip (coxarthrosis) or 
knee (gonarthrosis) joint. 
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Figure 2 Schematic illustration of rheumatic joint caused by wear (Röder, 2010) 
 
 The inflamed articular disease is the arthritis. The most prevalent form is the 
chronic polyarthritis that calls most often rheumatoid arthritis. The inflammation 
becomes recognizable early because of the redness, warmth and swelling of the joint. At 
the beginning of the disease a high fever can occur in several times. Autoimmune 
reactions trigger the inflammation which results that the immune system replaces 
cartilage with foreign body material or it also attacks. The causes of the autoimmune 
reaction are not yet known to science but presumed causes could be bacteria, viruses or 
mechanical cell damage. During activation of the immune system B lymphocytes 
produce antibodies (lgG) which induce new auto antibodies (rheumatoid factor). The 
lgG and the rheumatoid factor form an immune complex which is phagocyted by the 
granulocytes and cells of the synovial membrane. As a result cytokines released to 
ensure the maintenance of the inflammatory reaction. Cytokines in the rheumatic joint 
can be divided into three groups (Mutschler, 2001): 
- proinflammatory cytokines such as interleukin (IL)-1, -2, -6, -8, -15 and -18 or tumor 
necrosis factor alpha (TNF-α) regulate the inflowing and activation of the inflammatory 
effector cells (for exp. T-cells) and the proliferation of the chondrocytes and fibroblasts; 
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- anti-inflammatory cytokines such as IL-4, -10 and -13 inhibit purposefully the 
proinflammatory cytokines; 
- anti-cytokine protein such as the soluble TNF-α-receptor or the IL-1-receptor regulate 
the inflammation by catching the proinflammatory cytokine. 
 In the joint of the patient with rheumatoid arthritis all of the three types of 
cytokine can be found, but during the diseases it shifts the balance to the cytokines. 
Then the occurring inflammation starts from the synovial membrane (synovitis) which 
at first of all becomes thick, forming bumps and fibrous, stringy tissue projects forward 
(Figure 3) (Röder, 2010). The resulting tissue called pannus. In the pannus tissue a large 
number of antibodies can be found to lead to the destruction of cartilage. The 
rheumatoid arthritis can occur in all joints. Firstly, in the most cases it is formed in 
joints of hand and finger, but later it can spread in the knee and hip joints. The 
symptoms can be very strong especially at night and in the morning. Another (rarely 
occurring) two forms of inflammatory rheumatic diseases are known: psoriasis arthritis 
and Bechterew's disease. In both cases, the diseases are triggered by autoimmune 
reactions. 
 
 
Figure 3 Schematic illustration of rheumatic joint caused by inflammation (Röder, 
2010) 
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1.1.3. Drug therapies of rheumatic diseases 
 
In recent decades therapies and strategies have been pretty changed. During the drug 
therapies of rheumatic diseases the patient can have a shorter or longer period 
asymptomatically. The attenuation of pain is the most important aspect. Drug therapy 
especially considering the groups of active ingredients the following options are 
available: 
 non-steroidal anti-inflammatory drugs (NSAID); 
 non-steroidal antirheumatic drugs (NSARD); 
 glucocorticoids; 
 synthetic disease-modifying antirheumatic drugs (synthetic DMARD); 
 biological disease-modifying antirheumatic drugs (biological DMARD); 
 cartilage protector. 
 
 Cartilage protectors are the following substances: chondroitin sulfate, 
glucosamine, carrageenan and hyaluronic acid. They possess cartilage building 
characteristics. One of the most important is the HA. It is the lubricant for the cartilage 
and responsible for the viscosity of the synovial fluid. Due to the viscoelastic properties 
of HA, by the different moving of the joint (exp. sport), HA can have very different 
viscosity values. Thanks to this property, HA is a very versatile molecule. 
 There are a growing number of such active ingredients marketed as parenteral, 
solid or semisolid forms for rheumatic diseases. At this point it should be mentioned 
that parenteral biologicals make a greater number. According to an outlook to 2020 
worldwide the Rx drug sales add up to $1 trillion and the biological make up 52 % 
(Evaluate, 2014). 
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1.1.4. Intra-articular injections 
 
1.1.4.1. General about intra-articular injections 
 
Oral compositions (e.g. glucocorticoids, NSARD) have a great disadvantage for 
the treatment of rheumatic diseases: unpleasant systemic side effects may occur when 
taking. Undoubtedly, because of the poor bioavailability other active ingredients (e.g. 
HA) are used only for parenteral form. These problems can be avoided by using of i.a. 
injections Thus, due to the natural endowments of the joints the i.a. form is a very 
optimal input gate. In most of the cases the hand, knee and foot joints are affected and 
their good accessibility favors the intra-articular injections. From the synovial fluid only 
a little active ingredient enters the bloodstream and therefore systemic side effects are 
negligible. A very important drawback is the extremely high risk of infection during the 
use of i.a. preparations, especially for several consecutive injections (Albert et al., 
2006). However, the risk of infection is reducible by compliance with the standards, 
using sterile components and thorough disinfection of the injection site (Schumacher, 
2003). 
 
1.1.4.2. Modified release intra-articular drug delivery systems 
 
During the injections, there is the risk for infection therefore the number of 
injections in a year should be reduced. Also a long-term drug exposure should be 
achieved with an injection, and if it is possible, a combination of active ingredients 
should be used. Many different active ingredients could have a long-term drug exposure 
with carrier systems like micro- and nanoparticles (Szabó A. et al., 2012), liposomes 
(Foong et al., 1988; Lopez-Garcia et al., 1993; Elron-Gross et al., 2009), hydrogels 
(Réeff et al., 2012; Shah, 2001) and physically activated delivery systems like 
thermoresponsive (Betre et al.,  2006; Shamji et al., 2007; Kusanagi et al., 2007; Aly, 
2008) or magnetically modulated carriers (Butoescu et al., 2009). Almost every third 
knee articular injection is inaccurate (Brandt et al., 2003), which unnecessarily exposes 
patient to invasive therapy without improving the condition. 
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1.1.5. Requirements of intra-articular delivery systems 
 
Parenteral compositions also i.a. belong to the pharmaceutical formulations with 
the most stringent requirements. The following requirements shall be taken into 
account: 
 sterility; 
 pyrogen-free; 
 isotonic; 
 physiological pH; 
 viscosity; 
 compatibility of active ingredients and excipients; 
 contamination free; 
 compatibility with the packaging material; 
 stability during storage. 
 
The injectable suspension is one of the most complex pharmaceutical formulation 
considering their stability, production and application. By parenteral suspensions 
several factors should be taken into consideration (Liebermann et al., 1996): 
 dispersibility /sedimentation rate; 
 stability; 
 particle size; 
 syringeability. 
 
 For the intra-articular compositions the sterility is essential. The sterility of 
solutions can be achieved by wet and dry heat if during the process all of the active 
ingredients and excipients remain stable. The sterility of the other intra-articular dosage 
forms can be achieved with adequate preparation of the materials and by keeping the 
fully aseptic conditions (Gerwin et al., 2006). Sterile filtration is not feasible by 
formulations containing particles or by solid, semisolid forms. 
Ensuring isotonicity of the preparations is just as important as the sterility. Hypotonic or 
hypertonic parenteral preparations can cause pain or tissue damage (Bauer et al., 2002). 
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Therefore, it is very important to achieve an appropriate isotonic value which must be 
between 225 and 430 mOsm/kg. 
 The pH value should be set to the physiological pH (7.4). Greater deviations 
from the physiological value could cause pain. The minor differences can be 
compensated by the synovial fluid. 
 For the applicability of the product the viscosity plays a very important role. The 
higher viscosity can cause strong pain to the patients or the optimal syringeability could 
be difficult or even totally blocking. Syringeability is described by the Hagen-Poiseuille 
equation (Fry, 2014): 
 
 =
µ
	

        (Eq. 1) 
 
where: 
F = syringe stopper (plunger) force; 
Q = volumetric flow rate; 
µ = dynamic viscosity; 
L = needle length; 
D= needle bore diameter; 
A = syringe plunger area. 
 
 The syringe stopper or plunger force is dependent on numerous factors, 
including the volumetric flow rate, the dynamic viscosity, the needle length and bore 
diameter and the syringe plunger area, the relevant tissue. 
 The parenteral manufacturing industry pays great attention to particulate 
contamination. Particulate contaminations in parenterals are risk factors and can lead to 
damage to patients. Contaminations can be caused by interactions between the 
formulation, product packaging, packing materials, formulation ingredients, 
manufacturing process and environment (Langille, 2013). Quality by Design (QbD) is 
an important approach by parenteral manufactures. Quality is ensured by planning or 
design. The crises, risks and problems to get particulate contaminations can be avoided 
by well management of the different processes. The collaboration with logistic partners, 
DOI:10.14753/SE.2016.1870
15 
 
suppliers, technical engineering, glass manufacturers and the development of further 
testing methods (final visual inspections, measurement of changes in conformation that 
could lead to aggregation, using instruments for sub visible particles etc.) to avoid 
contaminations, is indispensable (Challener, 2014). QbD pays also attention to speed up 
the processing time and to reduce the costs. 
 The formulations could lose their stability during storage. Therefore some 
compositions are marketed as a dry powder which must be dispersed in a solvent before 
use (Gerwin et al., 2006). On the pharmaceutical market some products can be found in 
ready-to-use pre-filled syringe. The application of pre-filled injections avoids the 
critical point when the content of the vial is pulled up into the syringe which has new 
infection risks (Ayral, 2001). On the other hand the pre-filled syringes are also 
contributor to the increased incidence of problems with visible particulate 
contaminations (Challener, 2014). The inadequate time and temperature storage can also 
cause particulate contaminations in the parenteral preparations. 
 In the case of intra-articular suspensions the good and rapid and the slow 
sedimentation have an important role in the correct dosage of drugs. The remaining 
active ingredient(s) in the syringe can have serious consequences for the therapy. 
 The stability of the suspension is good if the particles are dispersible and do not 
agglomerate. 
 Several scientific articles were published about the optimum size of particles of 
intra-articular suspensions. Results of phagocytose of suspended parts are very 
different. So it should be noted, most of the literature suggests the avoidance of 
phagocytosis. Thus, the particles must be at least between 5 - 15 µm that exceeded the 
size of the macrophages and thereby prevent the annexation (Howie et al., 1993). 
 In parenteral considering i.a. injections a high number of excipients can be used 
safely. Water works as a solvent or dispersant. In most cases for isotonic sodium 
chloride, mannitol or sorbitol can be used. Sodium hydroxide, sodium hydrogen 
phosphate, hydrochloric acid, phosphoric acid or citric acid adjust the optimum pH 
value. In some of the products other excipients can be found: polysorbate 80 such a 
surfactant, sodium EDTA such a stabilizer, propylene glycol or polyethylene glycol 
such cosolvents and preservatives (benzyl alcohol, methyl- or propyl-4-hydroxy 
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benzoate and cetylpyridinium chloride) (Gerwin et al., 2006). For the stabilization of 
suspensions croscarmellose sodium, hypromellose or gelatine can be used. 
 There are a small number of intra-articular injections on the pharmaceutical 
market (Table 2). Mainly, glucocorticoids are available for the i.a. administration. 
However, an increasing number of publications have been published in the topic of i.a. 
delivery systems with NSAI and NSAR active ingredients. 
 
Table 2 Some commercially available i.a. products (without HA products) 
Commercial name Company Formulation Drug Concentration 
    (mg/ml) 
CELESTAN ® Depot MSD SHARP & 
DOHME GMBH 
suspension betamethasone 2.7 
CELESTAN ® solubile MSD SHARP & 
DOHME GMBH 
solution betamethasone 4 
Delphicort ® RIEMSER Pharma 
GmbH 
suspension triamcinolone 25; 40 
dexa-clinit ® Hormosan solution dexamethasone 4 
Dexamethason-mp ® medphano 
Arzneimittel 
GmbH 
solution dexamethasone 4 
Diprosone ® Depot MSD SHARP & 
DOHME GMBH 
suspension betamethasone 2 
Fortecortin ® Injekt Merck Serono solution dexamethasone 4; 8 
Lederlon ® RIEMSER Pharma 
GmbH 
suspension triamcinolone 5; 20 
Lipotalon ® Recordati Pharma 
GmbH 
liposome dexamethasone 2.5 
Prednigalen ® GALENpharma 
GmbH 
suspension prednizolone 10; 25; 50 
Prednisolut ® mibe GmbH 
Arzneimittel 
solution prednizolone 5; 12.5; 25; 50 
 
 In the last years the number of HA/sodium hyaluronate (NaHA) i.a. formulations 
increased (Table 3). Most of the preparation is in the form of a viscous solution, also 
known as hydrogel. HA is an innovative active ingredient with a lot of possible 
applications. 
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Table 3 Some commercially available i.a. HA products 
Commercial name Company Conc. Excipients 
  (mg/ml)  
ARTROject ® ORMED GmbH 5 NaCl, Na2HPO4, 
NaH2PO4, H2O 
Curavisc ® curasan AG 10 NaCl, Na2HPO4, 
NaH2PO4, H2O 
Fermathron ® Biomet Deutschland GmbH 10 NaCl, Na2HPO4, 
NaH2PO4, H2O 
GO-ON ® Rottapharm|Madaus GmbH 10 NaCl, Na2HPO4, 
NaH2PO4, H2O 
GO-ON ® matrix Rottapharm|Madaus GmbH 20 sorbitol 
Hya-ject  ® / -mini ORMED GmbH 10 NaCl, Na2HPO4, 
NaH2PO4, H2O 
Hya-ject ® plus ORMED GmbH 20 mannitol, NaCl, 
Na2HPO4, NaH2PO4, 
H2O 
Hyalart ® /D MEDA Pharma GmbH & Co. 
KG 
10 NaCl, Na2HPO4, 
NaH2PO4, H2O 
Hyalubrix ® MEDA Pharma GmbH & Co. 
KG 
15 NaCl, Na2HPO4, 
NaH2PO4, H2O 
Monovisc ® Plasmaconcept AG 22 NaCl, H2O 
Orthovisc ® / -mini Plasmaconcept AG 15 NaCl, H2O 
Ostenil ® / -mini TRB Chemedica AG 10 NaCl, Na2HPO4, 
NaH2PO4, H2O 
Ostenil ® plus TRB Chemedica AG 20 mannitol, NaCl, 
Na2HPO4, NaH2PO4, 
H2O 
Recosyn ® Recordati Pharma GmbH 10 NaCl, Na2HPO4, H2O 
Recosyn ® -m.d. Recordati Pharma GmbH 10 NaCl, Na2HPO4, H2O, 
citric acid 
Recosyn ® -forte Recordati Pharma GmbH 20 NaCl, Na2HPO4, 
NaH2PO4, H2O, Na2CO3 
Sinovial ® / -Mini / -
HighVisc 
IBSA Farmaceutici Italia Srl 8; 16 NaCl, H20, sodium 
phosphate (unknown) 
Synvisc ® / -One Sanofi-Aventis DL GmbH 8 NaCl, Na2HPO4, 
NaH2PO4, H2O 
Viscoseal ® TRB Chemedica AG 5 NaCl, Na2HPO4, 
NaH2PO4, H2O 
 
 Nowadays, it is very difficult to classify which formulations or applications are 
medical devices or drugs. This special emphasis is made on the regulatory issues of HA, 
too. The different countries have different opinion about the regulatory. There is no 
specification about the concentration, Mw, type of the application, viscosity, condition 
etc. of HA to classify to the medical devices or to the drugs. 
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1.2. Hyaluronic acid  
 
1.2.1. History 
 
 NaHA is the sodium salt of HA. There is a wide variety of names for HA which 
refers to the versatility of the material (Dicker et al., 2014). In 1934 Meyer et al. isolated 
it and called it HA because of his supposed mild acid properties. In the physiological 
medium, HA is present as a polyelectrolyte salt, calls “hyaluronate” with a cation, 
mostly with sodium, like “sodium hyaluronate”. Balazs et al. (1986) used the name 
“hyaluronan”, which form can be always used. 
 They are of importance in epidermal pathology, tissue engineering, ophthalmic 
surgery, drug delivery systems, pulmonary and joint pathologies and aesthetic surgery 
(Price et al., 2007). HA is the most important substance in the synovial fluid of articular 
joints to be found in the extracellular matrix of the synovium. It is the lubricant for the 
cartilage and responsible for the viscosity of the synovial fluid. Healthy joints contain 
approximately 2.26 g/l HA (Zeidler, 1986). It is a normal process that for people over 
the age of 30 years starts to lose HA production in body. Therefore, characteristics and 
formulations of HA are increasingly important in pharmaceutical technology. 
 The history of HA goes back to 1934 when Karl Meyer purified HA from the 
vitreous of bovine eyes (Meyer et al., 1934). In 1958, Meyer et al. identified the 
structure of HA. At the beginning of the researches the biggest challenge was the 
biological purity of HA. It was very difficult to remove all of the impurities from the 
molecule which can cause inflammation, irritation or allergy. In the late 1960s the use 
of the “non-inflammatory fraction of sodium hyaluronate” was started for therapeutic 
proposes. In the mid-1970s 1 % HA solution (2 – 3 million Da) was used in veterinary 
medicine. In 1992 the first HA with 6 million Da was usable for therapeutic applications 
(Balazs, 2009). 
 The first NaHA product for i.a. pathway with the name Hyalart®/Hyalgan® was 
marketed by Fidia in Italy in year 1986 (Fidia Pharma, 2015). It was used for the 
osteoarthritis of the knee. 
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1.2.2. Structure 
 
HA macromolecular chains are built from D-glucuronic acid and N-acetyl-D-
glucosamine disaccharides (Figure 4) (Kogan et al., 2007). A molecule of 10 million Da 
contains 25,000 disaccharide units in the chains, which are held together by 
hydrophobic bonds (Romagnoli et al., 2008). The polysaccharide chains are linear and 
unbranched and roll up into a coil conformation. The intramolecular hydrogen bonds 
have a big role in the conformation of HA. In solution the surrounding water molecules 
of HA causes another formation of hydrogen bonds. According to the concept of 
Sheehan et al. (Sheehan et al., 2001) the hydrogen bonds are not responsible for the 
stiffening of the molecule. There is a little difference in hydrogen bond energy whether 
the molecule is hydrogen bonded to itself or to water molecules. The different 
conformations are deal subsequently. 
 
 
Figure 4 Structural formula of HA 
 
 The length of the polysaccharide chains and the Mw of HA are very different in 
the various tissues. In normal tissues, a molecule of HA (10 million Da) has a thickness 
of 1 nm and a length of 25 µm (Romagnoli et al., 2008). In the biomatrix, HA has an Mw 
in the range of 6 to 12 million Da (Balazs, 2009). The molecular weight of HA is 
approximately 7 million Da in healthy joints and 4.8 million Da in unhealthy joints 
(Wohlrab et al., 2004). The viscoelastic properties of HA under 1 million Da are 
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negligible because of the Mw in flamed joints (4.8 million Da). For that purpose, cross-
linked HA is in demand (such as Hylan G-F 20, with an Mw of 6-7 million Da) for i.a. 
injections (Migliore et al., 2010). 
 HA can have very different molecular weights, from hundreds up to millions of 
Daltons, it gets interesting to determine the molecular weight of Ha. 
 Size-exclusion chromatography (SEC) is used for polymer molecular weight 
characterization, but it not suitable for the determination of the molecular weight of HA. 
It requires specific calibration standards. Multi-angle light scattering (MALS) detector 
can directly determine the molecular weight of a polymer without calibration standards. 
If SEC is combined with a refractometer as a concentration detector and a viscometer 
for measuring intrinsic viscosity (SEC-Triple), it becomes a powerful technique to 
characterize HA and other polymers (Sabagh et al., 2015). 
 Šoltés et al. (2002) successfully used SEC-MALS coupled with capillary 
viscometer for the molecular characteristics of some commercial high-molecular-weight 
HA. Caspersen et al. (2014) studied the kinetics and mechanism of depolymerisation of 
solid sodium hyaluronate at elevated temperatures and various pH. To develop an 
improved correlation between Mw and intrinsic viscosity for sixty HA batches with Mw 
ranging from 0.4 to 2.3 MDa, SEC with dual detection of multi-angle light scattering 
and refractive index (SEC-MALS-RI) was used. 
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1.2.3. Biological attributes 
 
Naturally, the HA molecules is synthesized inside the cells, for example, by 
endothelial cells, adventitious cells or oocytes (Romagnoli et al., 2008). In the 
synovium it is produced by synoviocytes, fibroblasts and chondrocytes. In the nature, 
the most of the HA amount can be found in rooster comb (7500 μg/ml), in human 
umbilical cord (4100 μg/ml), in human joint fluid (1400 – 3600 μg/ml), in bovine nasal 
cartilage (1200 μg/ml) and human vitreous body (140 – 340 μg/ml). The whole list of 
the tissues and body fluids with different HA content was published by Shiedlin et al. 
(2004). Approximately 11-17 g HA can be found in a human being (Laurent et al., 
1991).  
 HA can be animal or bacterial origin. The most animal origin HA is produced 
from rooster comb and the bacterial origin HA can be prepared from the capsules of 
streptococcus bacterium. Therefore, each product has slightly different rheological 
properties (Manna et al., 1999). The drawback of the animal HA is the impurities. The 
bacterial HA has no problem with biological purity and that is why it has a better and 
repeatable quality. In the European Pharmacopoeia there is a request concerning the 
amount of the bacterial endotoxin or pyrogens. These substances have to be limited in 
parenteral products at most 0.5 and by intra-articular or intra-ocular parenteral 
preparations 0.05 I.E. pro mg NaHA (Ph. Eur. 8., 2014). 
 
1.2.4. Physical and chemical properties 
 
In the physiological medium, HA is present as a hyaluronate salt, negatively 
charged and highly hydrophilic (Vasi et al., 2014). In general, it has the cation sodium 
[(C14H20NNaO11)n], but other cations are possible (like zinc, potassium, magnesium, 
calcium)  too. In solution HA has a much stiffened random coil structure. HA can have 
different conformations, which depend on the pH and the compounds of the solution. In 
1983 Sheehan et al. (1983) reported about a left-handed four-fold helical structure by 
sodium hyaluronate and a three-fold helix by calcium hyaluronate. In 2001, Sheehan et 
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al. published results with potassium hyaluronate and their different helical structure 
(studied by X-ray fiber diffraction) (Figure 5). Mainly the electrolytes and the solvents 
have an effect on the chain flexibility of HA (Gribbon et al., 2000). Calcium and 
manganese has a greater impact on the flexibility of HA chains,  while the chains are 
less flexible with sodium and potassium counter ions (Sheehan et al., 1983; Gribbon et 
al., 2000).  
 
 
 
 
Figure 5 X-ray fiber diffraction of potassium hyaluronate a) 2-fold helix conformation 
with an axial rise per disaccharide of 0.98 nm; b) left-handed 4-fold helix conformation 
with an axial rise of 0.84 nm per disaccharide and c) left-handed 4-fold helix of axial 
rise of 0.95 nm per disaccharide (Sheehan et al., 2001) 
  
a) b) c) 
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 The pH of the i.a. formulations has to have about 7.4 (as the physiological pH 
value of the synovial fluid) or slightly lower, but not below pH ~ 5.5 (Gerwin et al., 
2006). HA solution has pH between 6 and 7.2, therefore it is ideal for i.a. treatments. By 
decreasing pH (< 3) the carboxyl groups are protonated and HA form a water-insoluble 
gel (Wohlrab et al., 2004).  
 Under physiological condition HA with the carboxyl anion is able to bind a large 
amount of water. That is why the HA of 2 % in solution can bind 98 % water by 
forming a gel (Wohlrab et al., 2004). This gel - under physiological condition - shows 
viscoelastic and pseudoplastic characteristics and it is a non – Newtonian liquid.  
 In inflamed joints (e.g. in osteoarthritis, rheumatoid arthritis), the low viscosity 
is caused by increase of the volume of the synovial fluid and the reduction of the HA 
concentration and Mw (Marshall et al., 1997). Mw of HA has a significant effect on its 
half-life time. HA is metabolized very fast in the most tissues. The half-life time of HA 
with 6 million Da is about 13.2 h (Wohlrab et al., 2004). In different tissues HA has 
another length of the polysaccharide-chains, another Mw and that is why another half-
life time. HA has a longer half-life time in vitreous of the eyes then in articular joints. 
But this quantity depends on the replacing of the vitreous humor and the synovial fluids, 
too. Larsen et al. (Larsen et al., 2008) summarized the synovial disappearance half-lives 
and molecular weights of various solutes (lidocaine, diclofenac, hydrocortisone, 
hyaluronan, albumin). Hyaluronan has the longest half-life time in the synovial fluid, it 
is about 21.8 – 26.3 hours with 3 × 106 g/mol molecular weights. 
 Various HA derivatives can be achieved by chemical modification. Carboxyl 
groups of HA is especially suitable for this preparation. HA receptors and hyaluronidase 
recognize the carboxyl groups of HA (Banerji et al., 2007). Therefore, these derivatives 
can modify the enzymatic degradation of the molecule and accordingly the effect of 
HA. Mainly carboxyl and hydroxyl groups of HA are used for chemical modification, 
for example, with carbodiimide, divinyl sulfone, glycidyl ether or dialdehyde (Oh et al., 
2010). In order to produce hydrogels, HA derivatives are in strong demand, too. There 
are three types of HA whereby hydrogels are got, direct cross-linking of HA, cross-
linking of HA derivatives and cross-linking between two different kinds of HA 
derivatives (Oh et al., 2010). 
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 Maroda et al. (2011) prepared and characterized HA nanoparticles formed by 
amidation with an amine as a cross-linking agent in aqueous media. Cross-linked 
nanoparticles have a size less than 20 nm but during the purification it can be lost. 
 HA has an also great mucoadhesive property (Liao et al., 2005). HA creates 
bonds with the mucin in the mucous membrane and it causes longer residence time. 
Because of these mucoadhesive properties, HA is able to increase the absorption 
capacity of different drugs (Lim et al., 2000). 
 
1.2.5. Stability 
 
HA is a very unstable and heat sensitive molecule, the molecular mass and the 
viscosity may be decreased due to the damage of bonds in the polymeric chains (Bailey 
et al., 1968). If HA in solution is warmed up to 100 ºC, the bonds between the chains 
are get damaged, and the Mw and viscosity decrease. That is the reason why sterilizer 
with high temperature cannot be used for HA. 
 Thermal effect or treatments, pressure, ultrasonic effects, filtration, mixing or 
using syringe can destroy the chains. These chain scissions cause the reduction of the 
Mw and accordingly the reduction of the viscosity (Bailey et al., 1968).  
 It is well known that hyaluronates are susceptible to degradation under a variety 
of conditions such as acid hydrolysis (Cleland, 1977; Longas et al., 1981), oxidative 
depolymerisation reactions (Matsumura et al., 1966; Kvam et al., 1993), and sonication 
(Kubo et al., 1993). 
 But there is also another natural destroyer for HA, it is the degradation enzyme, 
hyaluronidase. Hyaluronidase breaks down HA very fast in the articular joints. The 
speed of the degradation depends on the Mw and the structure of the HA. Improved 
stability of HA can be achieved with cross-linking. Cross-linked HA has a higher half-
life time and can stay longer in the articular joints.  
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1.2.6. Hyaluronic acid-based hydrogel 
 
Gels are one-phase systems, the most common group, in which the gel medium 
is the water, are the hydrogel. The gelling materials can be different polymers, like 
polymethyl methacrylate (PMMA), poly-(2-hydroxyethyl)-methacrylate (polyHEMA) 
or polyvinyl alcohol (PVA) (Li et al., 2009). The polymers of the hydrogels are held 
together by physical, ionic or covalent bonds and can absorb water (Davidovich-Pinhas 
et al., 2010; Sriamornsak et al., 2008). The gel carriers for i.a. uses play a dual role in 
articular therapy: on the one hand gel carriers ensure longer residence time for active 
ingredients in the joints compared to the drug solution forms, and on the other hand 
through their viscosity they maintain the motility of joints such an artificial lubricant. 
Despite the many known artificial polymer systems in the development of 
pharmaceutical formulations, the endogenous HA and its various derivatives are the 
most preferred gelling material. Thus, the HA hydrogels used to help restore the 
physiological HA concentration, which increase the reduced viscosity. At present, in the 
therapeutic practice, only hyaluronic acid-based gels are applied (Orthovisc®, 
Monovisc®, Synvisc®, Biovisc®, Hyalgan®, Synocrom®, Synocrom Forte®) (Szabó A. et 
al., 2011). In in vitro studies, Réeff at al. (2012) with a HA gelling agent a release of 
several days (active ingredient clonidine) was reached. They used glyceryl monooleate 
as excipient for slowly soluble viscous phase in the synovial fluid (Shah et al., 2001).  
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1.2.7. Studies on the characteristics 
 
1.2.7.1. Viscometry 
 
Due to the chemical structure of the polymer, HA shows interesting rheological 
properties. The coils of HA can straighten, and this behavior is the mechanism of action 
behind viscosupplementation (Balazs et al., 1970). The aqueous solutions of high-
molecular-weight HA exhibit shear-dependent viscosity and frequency-dependent 
elasticity (Šoltés et al., 2002).  
The viscoelastic behavior of HA in solution changes with exposure to different 
shear rates. The shear rate is dependent on the dynamic elastic and viscous moduli. The 
crossover point of these two moduli can be used for the rheological characterization of 
HA. 
 
Figure 6 The viscoelastic behavior of HA and background of the viscosupplementation 
(brown: G' elastic dynamic modulus, blau: G'' viscous dynamic modulus; based on 
Balazs, 2009) 
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Above this frequency, the solution has elastic properties, and below this 
frequency it shows viscous behavior (Figure 6) (Balazs, 2009). This network, when 
sheared by flow or oscillation movements, can dissipate the energy in viscous flow or 
store it as elastic deformation (Gibbs et al., 1968). These rheological properties of HA 
provide viscous protection and elastic shock absorption in the joints (Phillips et al., 
2013). The more suitable viscosupplementation product is the one with an elastic 
component similar to or greater than that of healthy young synovial fluid (Phillips et al., 
2013). 
 In 1990 Hassan et al. have also used a simple viscometric method to quantify 
mucin-polymer bioadhesive bond strength. The mucoadhesive capacity was measured 
by a rheometer and this rheological behavior between the polymer and the mucin can be 
described by the following equation:  
 
ηb = ηt – ηm – ηp        (Eq. 2) 
 
where: 
ηb = bioadhesive viscosity component; 
ηt = viscosity of the mucin-polymer containing samples; 
ηm = individual viscosity coefficients of the mucin; 
ηp = individual viscosity coefficients of the bioadhesive polymer. 
 
1.2.7.2. Thermal analysis 
 
The thermal degradation of NaHA was evaluated by thermogravimetric analysis 
(Villetti et al., 2002) which indicated that low thermal stability can be observed for the 
polyanionic NaHA.  
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1.2.7.3. X-ray diffraction 
 
Guss et al. (1975) examined the molecular conformations and interactions in two 
sodium salts of HA. The results of X-ray diffraction showed that the counterions form 
strong intermolecular interactions with neighbouring HA molecules. Water molecules 
are attracted by the charged sites to form hydration shells. Guss et al. with X-ray 
experiments convinced that increasing the amount of water present in the hydration 
shells causes the reduction of the mechanical stiffness of the HA molecule.   
 Sheehan et al. (1983) used X-ray fiber diffraction to study of conformational 
changes in hyaluronate induced in the presence of sodium, potassium and calcium 
cations. The effects of pH, humidity, temperature, ionic strength and hydrogen ionic 
activity were studied in physiological situations. X-ray fiber diffraction method is a 
monitoring technique to illustrate the conformational changes. The results showed that 
the conformations of the chains are held together by stronger or weaker intra-chain 
hydrogen bonds. HA has in the presence of counterion sodium a left-handed four-fold 
helix form and in the presence of calcium a three-fold helical structure. These results 
were confirmed by the results of NMR studies, too (Almond et al., 2006).  
 
1.2.7.4. Spectroscopy 
 
Lee et al. (1993) reported about the tightly bound water (primary water) of 
hydration in Li- and NaHA. Brillouin spectroscopy was used to examine dynamic 
coupling with the water of hydration and phase transitions in HA. Their results were 
that the relaxation time of the water relaxation mode is approximately the same in Li- 
and NaHA and the coupling to the biopolymer depends on the biopolymer itself. 
 Ultraviolet spectroscopic studies of Lee et al. (1995) examined the physical 
properties of hyaluronate films. Taken together, two results of electronic states were 
reported; the elastic moduli of Li- and NaHA decrease over the entire range of hydration 
(this indicates that the long-range Coulombic interactions are very sensitive to the water 
content) and the changes in the UV spectrum of a NaHA film (before and after being  
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cycled through the phase transition between 84 and 92 % relative humidity) were found 
to be irreversible. 
 Infrared (IR) spectroscopy is used for the identification and classification of 
compounds and because of this unique characterization, it is often called “fingerprint” 
of the molecules. This experimental spectroscopy is very often used for polymers. In 
1954 Orr et al. used conventional IR spectroscopy for partial assignments of bands of 
HA and other hyaluronates. 
 In 1976 Cael et al. recorded spectra with Fourier Transform Infrared 
Spectroscopy (FTIR) for two different crystalline forms of NaHA. It is an improved 
technique for the analysis of solid, liquid and gas. A review of research papers about the 
variety of molecules (mono- and oligosaccharides, polysaccharides) examining by FTIR 
have been presented (Kačuráková et al., 2001). HA-phosphate fiber mats were 
examined by Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) 
spectroscopy (Brenner et al., 2013). HA fiber mats were produced with glycerol 
phosphate, sodium phosphate and tripolyphosphate salts. All display the characteristic 
carbohydrate peaks for HA. 
 Gilli et al. (1994) studied NaHA and its oligomers by FTIR spectroscopy in the 
amorphous solid phase and in aqueous solution. Dřímalová et al. (2005) depolymerised 
HA by ultrasonic, microwave irradiation and conventional heating, tested the effect of 
pH and oxidants on HA. This degradation and the molecular weight changes of HA 
were studied by FTIR spectroscopy. The results are in agreement with the previous IR 
study on HA from Gilli et al. (1994), the overall spectral pattern has not changed by 
decreasing the molecular mass of HA. Dřímalová et al. also reported about NMR 
studies with the HA samples. The NMR and also FT-IR spectral analyses indicated that 
HA in the studied whole molecular weight range retained almost the backbone of the 
parent polysaccharide independently on the degradation method used.       
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 The first time Lahajnar et al. (1986) reported on the proton nuclear magnetic 
resonance (NMR) spectroscopic study of water absorbed in solid, oriented NaHA. The 
results indicate a hydration similar to that of many other fibrous biopolymers at 
comparable relative humidity levels. Investigations using NMR in order to characterize 
the accurate solution conformation were mainly unsuccessful because of the overlap 
presents of the NMR spectra (Holmbeck et al., 1994; Donati et al., 2001). 
 Even so, Almond et al. (2006) successfully presented results about the solution 
conformation of HA determined by computer modeling (molecular dynamics 
simulations) and high-field nuclear magnetic resonance (NMR). The resulting data are 
used to test molecular dynamics simulations containing explicit water and ions at the 
atomic level. The results of this new description of the solution conformation of HA - a 
left-handed four-fold helix structure - are similar to that observed for potassium, sodium 
and calcium HA fibers by X-ray diffraction (Sheehan et al., 1983). The experiments of 
Almond et al. also pointed out that the intramolecular hydrogen bonds in HA exist in 
aqueous solution but they are constantly in motion and in rapid interchange with water-
mediated interactions. This simulation can be used as a basis for constructing molecular 
models to understand the interaction between HA and proteins, while also explaining 
the viscoelastic properties of HA. 
 
 
 
1.2.7.5. Positron annihilation lifetime spectroscopy 
 
Variation of the free volume with temperature in the sol-gel transition of 2 % 
(w/w) κ-carrageenan showed the sol-gel transition to be an onset of the decreasing 
percentage of the free volume (Wakabayashi et al., 1996). Positron annihilation lifetime 
spectroscopy (PALS) (Figure 7) (Szabó B. et al., 2011; Szabó B. et al. 2012) is able to 
give important information about the free volume properties of polymers related to their 
molecular dynamics, volume relaxation and physical ageing. 
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Figure 7 Method of PALS (A - real construction of PALS; B - schematic construction 
of PALS (Szabó B. et al., 2012)) 
 
 
 
 Sebe et al. (Sebe et al., 2012) have summarized the principles and the functions 
of PALS: the method is based on the annihilation of the electrons and positrons with 
high-energy γ-radiation. The electrons and positrons work as particle and antiparticle 
pairs and they destroyed mutually and finally they disappear or annihilate. During this 
process, the total mass of particle and antiparticle mutate to energy (photons without 
resting mass) according to Einstein equation E = mc2 (m is the mass of the particle, c is 
the speed of light and E is the released energy). This process produces energy without 
any side products, with 100 % efficiency. 
  
A 
B 
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 During the annihilation of positron and electron resulting generally two photons 
leave each other at an angle of 180°. This phenomenon can be used for research 
purposes. Before the annihilation of positron and electron there is another intermediate 
form, the positronium atom. There are two forms of positronium atom: if the positron 
and electron spin are the same (+1/2 or -1/2) (the spin of positronium atom is ± 1), then 
called orto-positronium (o-Ps) or if the spins are contrary (the spin of positronium atom 
is 0), then called para-positronium (p-Ps). The life of p-Ps is too short, it annihilates in 
vacuum in 125 ps during resulting two photons, but the o-Ps survives (because the 
contrary spins inhibit the annihilation). But, after a time the inhibition is not strong 
enough and the o-Ps annihilate during resulting three photons. Its lifetime in vacuum is 
142 ns. In polymers this lifetime can reduced to a few ns, because of the pick-off 
annihilation with an electron during resulting two photons as by p-Ps. This pick-off 
annihilation can be used to define the cavity size of polymers. The smaller the cavity of 
the polymer is, where the o-Ps passes, the faster it meets electron with contrary spin 
(Sato et al., 2008). 
 According Doppler-effect the velocity of the emitting source (in this case the 
electron during the annihilation) and the produced radiation (in this case the photons) 
may be measured. If in the polymer electron has energy (because of its velocity), it is 
added to the energy of produced photos. If the energy of annihilated photons can be 
measured, the momentum of electrons in the polymer cavity can be described. 
Generally, 22NaCl is used as positron source and two scintillation detector with BaF2 are 
needed. The detectors must be placed opposite each other as close as that goes (between 
the detectors is the polymer (Figure 7). The time between the two detectors sign is the 
lifetime of the positron. The resulting curve can be evaluated with different computer 
programs.  
 Only one publication in the past affects the topic hyaluronic acid examined with 
PALS. Süvegh et al. (2000) have tested the positron lifetime technique as a tool of the 
structure study of sodium and zinc hyaluronates. By zinc hyaluronate the positron 
lifetime significantly increased comparing sodium hyaluronate. And normally it would 
mean that the free volume between the chains of zinc hyaluronate has also increased. 
But this was not the case because in prior rheological studies (Burger et al., 2001) it was 
demonstrated that the free volume values in zinc hyaluronate decreased comparing 
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sodium hyaluronate and the o-Ps lifetime of zinc hyaluronate increased. The study 
reported about the different bonds: sodium salt has intermolecular hydrogen-bridge-
bonds and the exchange of cations (sodium to zinc) results intramolecular bonds. In the 
latter the chains curl up and that is why the free volume values decrease. This indicates 
that the intramolecular hydrogen-bridge-bonds are tauter and the o-Ps cannot access to 
the electrons so easy.   
 
1.2.8. Formulation aspects of hyaluronic acid 
 
1.2.8.1. Sterilization 
 
Sterility for the injection dosage forms of the HA derivatives can be achieved 
only by sterile filtration of the solution or with the application of sterile solid HA treated 
by gamma irradiation (5 – 10 kGy) (Wohlrab et al., 2004). 
 Experiments with “ready-to-use pre-filled” HA syringe showed that by 
autoclaving for 20 min, the Mw decreased from 1.4 million Da to 0.8 million Da. By this 
gamma ray intensity the number of the chain scissions is acceptable and the results are 
repeatable. 
 Barbucci et al. (2002) investigated the sterilization of lyophilised cross-linked 
HA (synthesized from 50 % with COOH groups cross-linked HA). It was sterilized with 
steam, γ-rays and ethylene oxide. The swelling ability and morphology of HA were not 
modified by sterilization with ethylene oxide and γ-rays. The steam sterilization caused 
modifications of this type of HA.   
 However, data from simulated sterilization conditions suggest that higher 
concentrations of HA may have a protective effect on the stability of the long-chain 
molecule, such that heat treatment would not denature the hydrogel (Ali et al., 2009).  
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 Furthermore, Novozymes Biopharma was dedicated to providing a Bacillus-
derived high-quality HA. No animal-derived raw HA provides superior heat stability for 
more efficient sterilization process (Novozymes, 2012). The investigations of Szabó A. 
et al. (2013) showed that the heat sterilization modified both the micro- and 
macrostructures of the NaHA (animal derived) gels depending on the concentration and 
therefore it is not a suitable method to achieve the sterility. 
 
 
 
1.2.8.2. Freeze-drying 
 
Freeze-drying process (lyophilisation) is a treatment to get chemically stable and 
sensitive substances more sustainable and it should be taken into consideration that it is 
also able to reduce the number of the bacteria in the formulation because of the very low 
temperature during the treatment. However, the freeze-drying and subsequent 
rehydration of thermosensitive polymer gels, like hydroxypropyl cellulose (HPC), could 
alter the microstructural properties of the gels in a way that leads to rapid shrinking 
rates (Kato et al.,  2004). 
 Earlier data indicated that lyophilisation of hyaluronates as the free acid, in 
contrast to the sodium salt form, can have a detrimental effect on their physical 
characteristics (Doherty et al., 1994). The data of Doherty et al. (1994) indicate that the 
free acid form of medium molecular mass hyaluronate exhibited marked changes in 
molecular mass during lyophilisation whereas the NaHA appeared unchanged. 
 Measurements showed that the evolution of carbohydrate radicals on freeze-
drying of HA is more than three times that of NaHA, which explained that HA is 
structurally less stable than NaHA (Tokita et al., 1997). Further, the calculations of 
Tokita et al. suggest that HA is much more labile against hydrogen abstraction as 
compared to NaHA. 
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 The results of Wedlock et al. (1983) suggest that the structural stability of HA 
against a distortion induced by freeze-drying is lower than that of NaHA. Concerning 
the stability of hyaluronate during freeze-drying, significant concentration effects would 
occur with respect to the hyaluronate, and it is possible that a combination of 
concentration effects and shifts in the effective pH of the amorphous reaction matrix 
could contribute to the apparent changes in molecular mass. Furthermore, this 
hypothesis concerning and pH effects is consistent with the observed stability of NaHA 
to lyophilisation as the pH of those solutions was near neutral (Doherty et al., 1994). 
 The changes of the NaHA microstructure were studied by positron annihilation 
lifetime spectroscopy (PALS) in the course of the lyophilisation that gives information 
about the free volume of the polymer systems. This measurement can be used for the 
analysis of amorphous materials like NaHA (Zelkó et al., 2006). 
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2. Aims 
 
Many people have joint problems and therefore, the intra-articular delivery 
system provides a very promising solution for the therapies. An increasing number of 
HA injections appears on the international market, and this point shows the interest in 
this product. This molecule is also very manifold but the handling and the working with 
them are not so easy for the pharmaceutical industries. Because of the sensitivity of the 
molecule many processing and manufacturing processes are not cleared up. 
 The aim of this research work was to study the formulation of sodium 
hyaluronate gels of different concentrations for intra-articular application. Another 
purpose was to clarify the microstructural changes due to the manufacturing process, 
namely the effect of heat sterilization and freeze-drying.   
 
The objectives of the research were as follows: 
(i) to formulate NaHA hydrogels intended for parenteral (intra-articular) 
administration, 
(ii) studying the effect of heat sterilization of NaHA hydrogels considering 
the microstructural changes (changes in the polymeric free volume and 
free volume distribution) and viscoelasticity, 
(iii) evaluation of the effect of freeze-drying on the microstructure and 
rheological behaviour of NaHA hydrogels  
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3. Materials and methods 
 
3.1. Materials 
 
3.1.1. Active ingredient 
 
NaHA of low molecular weight (Mw = 1,500 kDa) has an animal origin, and is 
produced from rooster comb. The pharmaceutical grade of NaHA was obtained from 
Gedeon Richter Ltd., Budapest, Hungary. The water content of the raw NaHA was 9,5 ± 
1,37 %. 
 
3.1.2. Excipients 
 
Na2HPO4 and NaH2PO4 were used as isotonic sodium phosphate puffer (19.543 
g Na2HPO4 x 2 H2O and 2.425 g NaH2PO4 x 0 H2O ad 1000 ml water). The puffer had 
pH 7.554 and an osmolarity of 286 mOsm/kg. The pharmaceutical grade was obtained 
from VWR International Ltd., Debrecen, Hungary.  
 
3.2. Methods 
 
3.2.1. Preparation of hydrogels 
 
NaHA hydrogels of 5, 7.5 and 10 mg/ml concentration were prepared. At first 
the polymer was swelled in sodium phosphate buffer during 24 hours. Table 4 shows 
the measured parameters (concentration, pH, osmolarity) during the production.  
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Table 4 Product parameters of NaHA hydrogels 
Samples Autoclaving Freeze-drying 
Concentration (mg/ml) 5, 7.5, 10 5, 7.5, 10 
pH 7.44 - 7.45 7.50 - 7.55 
Osmolarity (mOsm/kg) 218 - 286 294 - 311 
 
 
In the second part of the thesis 10 mg/ml NaHA hydrogels were prepared with 
water (without sodium phosphate puffer). The polymer was swelled in water during 24 
hours. The pH and the osmolarity were 6.416 and 0.006 Osm/kg. 
 In both of the case, the hydrogels mixed with a glass rod at room temperature 
and stored foil sealed in refrigerator for 24 hours. After 24 hours the evaporated water 
was completed and again homogenized by a glass rod. 
 
3.2.2. Heat sterilization 
 
 The samples were studied without any further treatment at two hours and at one 
week after autoclaving (Boxer autoclave 30075LR, Boxer Laboratory Equipment Ltd, 
UK) at 121 °C for 20 minutes, 103.4 kPa. The untreated and heat sterilized gels were 
stored at a temperature of 22 ±0.5 °C and a relative humidity of 55 ± 2 %. 
 
3.2.3. Freeze-drying 
The freeze-drying was performed in Scanvac CoolSafe 100-9 Pro type equipment 
(LaboGene ApS, Lynge, Denmark) equipped with a 3 shelf sample holder unit, recessed 
into the drying chamber. The process was controlled by a computer program (Scanlaf 
CTS16a02), the temperature and pressure values were recorded continuously. 
The temperature of the drying chamber was between (-96) °C – (-92). Freezing of the 
samples was performed in the drying chamber. 
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3.2.4. Thermal analysis 
 
Thermogravimetric (TG) analysis of NaHA was registered out on a METTLER 
Toledo TGA/DSC 1 (Mettler-Toledo AG, Greifensee, Switzerland) system, in nitrogen 
atmosphere with a flow rate of 50 ml/min, at a heating rate of 10 °C/min in the 
temperature range of 25 - 300 °C with sample weight of 8 - 15 mg in capsules of 
aluminium as sample containers. 
 The differential scanning calorimetry (DSC) measurements were carried out on a 
METTLER Toledo 821e DSC (Mettler-Toledo AG, Greifensee, Switzerland) system. 
Under the Ar atmosphere with a flow rate of 100 ml/min samples with weight of 3-5 mg 
were measured at a heating rate of 10 °C/min in a temperature range of 25 - 300 °C and 
also in capsules of aluminium as sample containers. The measured data were registered 
with STARe software. 
 
3.2.5. Reconstitution 
 
 For the reconstitution 5 g raw NaHA and 5-5 g the freeze-dried NaHA samples 
were dissolved in 5 ml water. The water was very slowly added by injection. It was 
measured how much time the dissolution and the hydration needed to get a hydrogel. 
The timescale was noticed during 2 min. 
 
3.2.6. Rheological measurements 
 
Rheological measurements were carried out with a Kinexus Pro rheometer 
(Malvern Instruments Ltd, UK). The measured data were registered with rSpace for 
Kinexus Pro 1.3 software. A cone and plate geometry was used for the measurements. 
The gap between the cone and plate of sample placement was 0.03 mm. The diameter of 
the cone was 50 mm. The quantity of the samples was 0.57 ml. The temperature of the 
samples was controlled within 37 ± 0.1 °C by a Peltier system. For the analysis of 
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viscoelasticity, the storage (G’) and loss modulus (G’’) of shear were plotted against the 
frequency, and their points of intersection were analyzed. 
 
3.2.7. Surface morphology 
 
The scanning electron microscopy (SEM) of the raw and freeze-dried NaHA was 
investigated by scanning electron microscopy (Hitachi S4700, Hitachi Scientific Ltd., 
Japan). A sputter-coating apparatus (Bio-Rad SC 502, VG Microtech, Uckfield, UK) 
was applied to induce electric conductivity on the surface of the samples. The air 
pressure was 1.3-13.0 mPa. Briefly, the samples were sputter-coated with gold-
palladium under an argon atmosphere, using a gold sputter module in a high vacuum 
evaporator (0.1 Pa), and the samples were examined with the SEM instrument set at 10 
kV (current 10 µA). 
 
3.2.8. Positron annihilation lifetime spectroscopy 
 
The source was covered by very thin foils. Due to the exponential penetration of 
the radiation, a larger intensity and smaller variation of the o-Ps lifetime could be 
obtained than with regular foil of 20-25 µm. Approximately 150 µl (2-3 drops) from 
each homogeneous polymeric gel was poured onto the foil. The solvent evaporation was 
prevented by a cylindrical metal cover. 
 For positron lifetime measurements, a positron source made of carrier-free 
22NaCl was used. Its activity was around 106 Bq and the active material was sealed 
between two very thin foils. Lifetime spectra were measured with a fast-fast 
coincidence system based on BaF2/XP2020Q detectors and Ortec® electronics. Every 
spectrum was recorded in different channels of an analyzer card for different time and 
each contained about different coincidence events (Table 5). The number of coincidence 
counts was inevitably slightly lower than normal because of the increased distance 
between the two detectors. The detectors were arranged vertically in this experimental 
setup. An aluminium plate was placed on the lower detector. Although a great number 
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of positrons were lost using this arrangement, the significant part of the signal remained 
intact. As the aluminium does not produce an o-Ps component, any signal in that certain 
lifetime range came exclusively from the gel (Szabó B. et al., 2012). The temperature 
during the measurements was 22 ± 0.5 °C.  
 Three parallel spectra were measured at each concentration to increase 
reliability. After summarizing the parallels, spectra were evaluated by the 
RESOLUTION computer code (Kirkegaard et al., 1981); the indicated errors are the 
deviations of the lifetime parameters obtained. Three lifetime components were found in 
all the samples. The MELT code (Shukla et al., 1993) was used to extract lifetime 
distributions from the spectra. These latter evaluations were used to characterize the size 
distribution of free volume holes in the samples through o-Ps lifetime. 
 
 
Table 5 Different process parameters for PALS measurements 
 Sterilization Freeze-drying 
Foils for active materials Kapton Ti 
Channels 4096 3050 
Time (s) 9000 1800 
Coincidence events 1.5 × 106 106 
 
 
3.2.9. Karl Fischer water content determination 
 
The water content was determined using a Karl Fischer titrator (787 KF Titrino type, 
Metrohm AG, Herisau, Switzerland). Prior to the titration of the sample the water 
equivalency factor of Hydranal is determined using sodium tartrate (Hydranal water 
standard, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). The water 
equivalency factor was determined with 6 parallel measurements and the average of the 
results was used as the calibration for the samples. The solvent was extra dry methanol, 
which was titrated to the electrometric end-point with Karl Fischer reagent (Hydranal-
composite 5, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) before the 
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measurement. Approximately 100 mg sample was accurately weighed and immediately 
transferred to the titration vessel. After dispersing the sample (1 min at 15000 rpm) it 
was titrated with Karl Fischer reagent until the end-point. Each sample was analyzed in 
triplicate. 
 
3.2.10. X-ray powder diffraction 
 
Structural analysis was examined by X-ray powder diffraction (XRPD). XRPD spectra 
were recorded with a Bruker D8 Advance X-ray diffractometer (Bruker AXS GmbH, 
Karlsruhe, Germany) system with Cu Kλl radiation (λ = 1.5406 Å) over the interval 3° - 
40° (2θ). The measurement conditions were as follows: target, Cu; filter, Ni; voltage, 40 
kV; current, 40 mA; time constant, 0.1 s; angular step 0.007°. 
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4. Results 
 
 The investigations were focusing to examine the influence of heat sterilization 
and NaHA concentration on the micro- and macrostructure of NaHA hydrogels. NaHA 
hydrogels of different concentrations were prepared and heat sterilized. The 
microstructures of the polymer gels were characterized by PALS based on their o-Ps 
lifetime values and distributions, while their macrostructures were characterized by 
rheological measurements. It was believed, that the heat sterilization modifies both the 
micro- and macrostructures of the gels and the NaHA concentration is also observed to 
influence the hydrogel structure. 
 After the investigation of the sterilization, the freeze-drying ability of the 
hydrogels was examined. However the freeze-drying is not a sterile procedure, it could 
make simpler and speed up the production process and the application. But then each 
ingredient should be sterilized in accordance with the properties of materials and these 
should be freeze-dried under aseptic conditions.   
 Aqueous NaHA gels were prepared and the obtained samples were freeze-dried. 
It has been observed how fast the gelling ability is meanwhile preserved their initial 
viscoelasticity even after reconstitution. The microstructure of gels obtained from raw 
substance and freeze-dried NaHA samples was characterized with PALS and X-ray 
diffraction patterns, while their functionality-related macrostructural properties were 
tested based on their rheological behavior. Furthermore, thermogravimetric, differential 
scanning calorimetry measurements, surface morphology and Karl Fischer water 
content determination were used for the tracking of the structural alterations. 
These properties may be advantageous in the development of a freeze-dried NaHA 
injection dosage form. 
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4.1. Heat sterilization 
 
4.1.1. Formulation and characterization of sodium hyaluronate gels 
 
 At the beginning of these studies, some product was summarizing from the 
present pharmaceutical market (Table 2 and 3). The concentrations of the sodium 
hyaluronate product were researched but there was no information about the Mw of the 
formulations. Therefore, NaHA with Mw = 1,500 kDa was used and three different 
concentrations (5.0, 7.5 and 10.0 mg/ml) was taken.   
 The samples with the three different concentrations were prepared and were heat 
sterilized at 121 °C for 20 min. Additionally, the samples were studied without any 
further treatment at two hours and at one week after autoclaving. The untreated and heat 
sterilized gels were dried at a temperature of 22 ± 0.5 °C and had a relative humidity of 
55 ± 2 %. The untreated (without autoclaving), treated after two hours and one week (at 
two hours and at one week after autoclaving), untreated dried and treated dried samples 
have been compared in the next chapters.  
 
4.1.2. Structural elucidation of sodium hyaluronate gels 
 
4.1.2.1. Positron annihilation lifetime spectroscopy 
 
 
 On first time the untreated NaHA gels and the treated NaHA gels at two hours 
and at one week after autoclaving were compared. The Figure 8 (A-C) shows the o-Ps 
lifetime distributions of these samples of various concentrations. 7.5 mg/ml NaHA gels 
(Figure 8B) showed the smallest changes in the o-Ps lifetime values before and after 
heat sterilization.  
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Figure 8 A-C Lifetime distribution curves of the HA gels of different concentrations 
(black: untreated sample, red: treated sample; blue: one week after the treatment) A – 
5.0 mg/ml HA, B – 7.5 mg/ml HA, C – 10.0 mg/ml HA (Szabó A. et al. 2013) 
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Table 6 also represents the changes of the o-Ps lifetime values of the gels and dried 
samples before and after heat sterilization. At 5.0 mg/ml NaHA concentration, a close-
packed structure is formed while in the case of 10.0 mg/ml NaHA, it is the formation of 
a more open structure, thus the distance between the NaHA chains increases. The 
sample with 7.5 mg/ml concentration has the least distribution which shows the 
structural stability of the hydrogel after sterilization.  
At 10 mg/ml NaHA, the structural change was reversible; after one week of storage, a 
chain relaxation occurred (Figure 8C).  
 
 
Table 6 Summarised results from RESOLUTION computer code (o-Ps lifetimes in ns)  
(Szabó A. et al. 2013) 
Concentrations Untreated Treated After 1week Dried Treated, dried 
5.0 mg/ml 1430 ± 15 1380 ± 11 1389 ± 11 1102 ± 37 1093 ± 40 
7.5 mg/ml 1393 ± 11 1396 ± 11 1405 ± 13 1095 ± 21 1094 ± 25 
10.0 mg/ml 1400 ± 12 1465 ± 12 1390 ± 12 1118 ± 23 1131 ± 16 
 
 
 
 Figure 9 illustrates the o-Ps lifetimes distributions of 5.0, 7.5 and 10.0 mg/ml 
dried samples before and after autoclaving. The effect of the heat treatment on the dried 
samples was different. However, in case of the 7.5 mg/ml sample, the microstructure 
was not significantly changed by the heat treatment. 
 Table 7 presents the uniformity of the free volumes based on full width at half 
maximum (FWHM) of the fitted Gaussian curves. In case of 7.5 mg/ml NaHA gels, the 
least distribution is discernible.  
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Figure 9 Lifetime distribution curves of the dried samples of different concentrations 
(black: 5.0 mg/ml, red: 7.5 mg/ml, blue: 10.0 mg/ml; square: untreated dried samples, 
triangle: treated dried samples) (Szabó A. et al., 2013) 
 
 
 
 
Table 7 o-Ps distribution curve parameters (center and FWHM) in ns (Szabó A. et al., 
2013) 
Sample 
Untreated Treated After 1 week 
Center FWHM Center FWHM Center FWHM 
5.0 mg/ml 1.4820 0.1070 1.3820 0.0732 1.4070 0.1244 
7.5 mg/ml 1.4070 0.0912 1.4190 0.0951 1.4320 0.1299 
10.0 mg/ml 1.4190 0.1002 1.5200 0.1125 1.4070 0.1041 
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4.1.2.2. Viscoelasticity 
 
 
 Viscometric studies were accomplished to get information about the 
microstructural characteristics of the samples. The rheological behavior of the NaHA 
gels is demonstrated as a function of increasing frequency. 
Figure 10 shows the viscoelastic curves of the 7.5 mg/ml NaHA gel before and after 
treatment. The autoclaving did not cause significant changes of the transition point. 
 
 
 
 
Figure 10 Viscoelastic curves of the 7.5 mg/ml NaHA gels (black: storage modulus; 
green: loss modulus; line: untreated sample; dashed line: treated sample at two hours 
after autoclaving; dotted line: treated sample at one week after autoclaving) (Szabó A. et 
al., 2013) 
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 The elastic and viscoelastic properties of NaHA at three different concentrations 
were compared in Figure 11. The autoclaving degraded the gel structure in case of the 5 
mg/ml sample, the decrease of the viscoelasticity can be observed. The viscoelastic 
nature of the two other gels containing 7.5 and 10.0 mg/ml NAHA was maintained. The 
temperature dependence does not play a role. 
  
 
 
Figure 11 Effect of the HA concentration and the heat sterilization on the intersection 
of the viscoelastic curves of the samples (blue columns: untreated samples; red 
columns: treated samples; green columns: samples one week after the treatment) (Szabó 
A. et al., 2013) 
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4.2. Freeze-drying 
4.2.1. Formulation and characterization of sodium hyaluronate gels 
 
 In the first series all of the samples with three different concentrations (5.0, 7.5, 
10.0 mg/ml) in sodium phosphate buffer were tested by PALS and the viscoelastic 
properties were obtained. 
 In the next series of experiments three different formulations were examined to 
get explanation what happens with the NaHA structure in the presence of phosphate 
buffer after freeze-drying (raw NaHA, freeze-dried NaHA gel of 10 mg/ml prepared 
with water and freeze-dried NaHA gel of 10 mg/ml prepared with sodium phosphate 
buffer). 
 Thereafter the gels were freeze-dried. The temperature of the drying chamber 
was between (-96) °C – (-92) °C. Freezing of the samples was performed in the drying 
chamber. The process parameters are shown in Table 8 and in the next diagram (Figure 
12). 
 
Table 8 Process parameters of freeze-drying of hydrogels 
Process Time Product temperature Shelf temperature Pressure 
 (hour:min) (°C) (°C) (hPa) 
freezing 00:00 21 27 69 
 
 
00:01 - 00:30 27 - 21 27 - 17 725 - 707 
 
 
00:31 - 01:04 20 - 0 16 - (-7) 690 - 673 
 
 
01:05 - 02:06 -1 - (-8) -8 - (-20) 673 - 656 
 
drying 02:07 - 20:38 -8 - (-35) -20 - 19 43 - 0.02 
secondary  
drying 20:41 – 28:11 -34 - (-19) 34 - 41 0.02 - 0.017 
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Figure 12 Diagram to the freeze-drying process of hydrogels (red: chamber 
temperature, green: product temperature, yellow: shelf temperature, blue: pressure) 
 
 Figure 13 shows the NaHA hydrogels after freeze-drying prepared with sodium 
phosphate buffer and with water. The sample with phosphate puffer has a higher 
volume which can be concluded from the very porous structure. 
 
 
Figure 13 Freeze-dried 10.0 mg/ml NaHA hydrogel samples with sodium phosphate 
buffer (left) and with water (right) (each glass ampoule contain 5 g of the sample) 
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4.2.2. Structural elucidation of sodium hyaluronate gels 
 
 In the first series the following experiments were performed: PALS 
measurements with hydrogels and freeze-dried NaHA hydrogels with 5.0, 7.5 and 10.0 
mg/ml in sodium phosphate buffer. 
 
 Figure 14 shows the o-Ps lifetime values of hydrogel samples. The most 
significant supramolecular change, indicated by the greatest difference in the o-Ps 
lifetime values, can be observed in the case of hydrogels of the lowest NaHA (5.0 
mg/ml) concentrations. The smallest difference in the supramolecular change is by the 
NaHA hydrogel with 10.0 mg/ml concentration.  
 
Figure 14 o-Ps lifetime values of various gel samples (I.G - III.G: NaHA hydrogels of 
5.0, 7.5, 10.0 mg/ml polymer concentrations in sodium phosphate buffer; IV.G - VI.G: 
freeze-dried NaHA hydrogels of 5.0, 7.5, 10.0 mg/ml polymer concentrations in sodium 
phosphate buffer; S.G: NaHA raw substance (powder)) 
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 Support for the previously obtained results, furthermore NaHA hydrogel with 
10.0 mg/ml was examined. The following experiments were performed: raw substance 
NaHA, freeze-dried NaHA hydrogel of 10.0 mg/ml prepared with water and freeze-
dried NaHA hydrogel of 10.0 mg/ml prepared with sodium phosphate buffer. The 
structural alteration was investigated. 
 
 
4.2.2.1. Reconstitution 
 
 The water content of the samples was determined by Karl Fischer titration. In all 
three cases the values were very similar: raw substance:  9.5 ± 1.37%; freeze-dried 
NaHA gel prepared with water: 10.36 ± 1.41%; freeze-dried NaHA gel prepared with 
phosphate buffer: 9.35 ± 1.76%.  
During reconstitution or gelling process, 5 ml water was added by injection to 5 g 
sample. The time which needed to get a gel from the freeze-dried substance was 
measured. Despite of the similar water content values, the gelling of NaHA was much 
different during reconstitution.  
 
 The timescale of gelling from raw substance and freeze-dried samples was 
demonstrated in Figure 15. The reconstitution of the freeze-dried NaHA gel containing 
sodium phosphate buffer was completed within 2 min. In comparison with that the 
gelling process of the freeze-dried gel prepared with water was not carried out after 2 
min. It required longer time. In contrast to the freeze-dried gels, the complete gelling 
process of the NaHA raw substance required several hours. 
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Figure 15 Tracking of the dissolution and gelling of freeze-dried NaHA (10.0 mg/ml) 
during reconstitution with water (A – raw substance in powder form; B – freeze-dried 
NaHA prepared with water; C – freeze-dried NaHA prepared with phosphate buffer) 
(Krüger-Szabó et al., 2015) 
 
 
 
4.2.2.2. Viscoelasticity 
 
Figure 16 demonstrates the effect of freeze-drying on the viscoelastic behavior 
of NaHA hydrogels prepared from water or from sodium phosphate buffer in contrast to 
NaHA gel prepared from the raw substance. 
  
           0 s                            30 s                              60 s                            120 s 
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Figure 16 Viscoelasticity of NaHA gels (10.0 mg/ml) prepared from both the raw 
substance and the reconstituted freeze-dried gels (blue: reconstituted freeze-dried gel 
prepared with water; red: reconstituted freeze-dried gel prepared with phosphate buffer; 
green: gel prepared from raw substance; line: storage modulus; dashed line: loss 
modulus)   
 
 In case of all three samples, the transition point was not significantly changed, 
which means that the samples held their viscoelastic properties.  
 
4.2.2.3. Thermal analysis 
  
 The already mentioned lower o-Ps lifetime values and the consequent smaller 
free volume holes of the reconstituted freeze-dried gels indicate that less water 
remained, which is shown by TG curves (Figure 17). It can be seen that the raw NaHA 
and freeze-dried NaHA in water contain more water than the freeze-dried NaHA in 
buffer. At the temperature of 240 °C NaHA shows a total degradation. 
f (Hz) 
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Figure 17 Effect of freeze-drying on the TG curves of 10.0 mg/ml freeze-dried NaHA 
in phosphate buffer (1), 10.0 mg/ml freeze-dried NaHA in water (2) and raw NaHA (3) 
 
 DSC was used to identify the amount of water and the binding processes 
between hyaluronates and water (Takigami et al., 1993; Takigami et al., 1995). The 
DSC curves (Figure 18) for 10.0 mg/ml freeze-dried NaHA in buffer, 10.0 mg/ml 
freeze-dried NaHA only in water and raw NaHA were registered up to 300 °C. The 
endothermic peak of the DSC curves presents the loss of the moisture content until ca. 
160 °C. Afterwards NaHA disintegrates with the exothermic peak at the temperature of 
240 °C by raw NaHA and a little bit earlier by freeze-dried NaHA gels. 
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Figure 18 Effect of freeze-drying on the DSC curves of 10.0 mg/ml freeze-dried NaHA 
in phosphate buffer (1), 10.0 mg/ml freeze-dried NaHA in water (2) and raw NaHA (3) 
 
 
 
 
4.2.2.4. XRPD 
  
Figure 19 demonstrates the X-ray diffraction pattern of the different samples. After 
freeze-drying no amorphous-crystalline transition of NaHA can be observed. The only 
samples that showed a crystalline character were the two types of sodium hydrogen 
phosphates. 
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Figure 19 X-ray powder diffraction pattern of various samples (1 – freeze-dried NaHA 
prepared with phosphate buffer; 2 – freeze-dried NaHA prepared with water; 3 – NaHA 
raw substance; 4 – monobasic sodium hydrogen phosphate; 5 – dibasic sodium 
hydrogen phosphate) (Krüger-Szabó et al., 2015) 
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4.2.2.5. SEM  
 
Figure 20 A-C visualizes the changes in the microstructure of the NaHA samples after 
freeze-drying. The SEM photos highlight the visible alteration of the structure.  
 
Figure 20 SEM photos of NaHA samples (A – raw substance; B – freeze-dried NaHA 
gel of 10 mg/ml concentration prepared with water; C – freeze-dried NaHA gel of 10 
mg/ml concentration prepared with phosphate buffer) (Krüger-Szabó et al., 2015) 
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The raw substance (Figure 20 A) showed aggregated micron sized small particles. 
Figure 20 B-C demonstrated continuous porous matrix after freeze-drying. An internal 
“ladder-like” structure with a very noticeable porosity can be observed in Figure 20 C, 
in which NaHA gel was prepared with sodium phosphate buffer and afterwards it was 
freeze-dried. 
 
4.2.2.6. o-Ps lifetime values 
 
 Figure 21 shows the decreased o-Ps lifetime values and the consequent lower 
free volume holes. By the freeze-dried NaHA gel prepared with phosphate buffer, this 
could be explained with the increasing number of the pores and the reduction of their 
size. 
 
 
 
Figure 21 o-Ps lifetime values of various NaHA samples (10.0 mg/ml) (Krüger-Szabó 
et al., 2015) 
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5. Discussion 
 
 
5.1. Effect of the heat sterilization 
 
 
 Based on some literature data (Ali et al., 2009; Novozymes, 2012), that is 
already succeeded NaHA to sterilize with heat. The aim of this step was to learn more 
about the alteration of the structure of NaHA by heat sterilization. 
 The results from the autoclaving process indicated that the energy of heat 
sterilization modified the supramolecular structures of NaHA depending on its 
concentration in the aqueous gel system.  
 After heat sterilization and measurements by PALS, a close-packed structure 
was showed by 5.0 mg/ml NaHA sample, while a more open structure by 10.0 mg/ml 
NaHA concentration. At 7.5 mg/ml NaHA, there was no significant change in the 
polymer structure, in contrast to the other two concentration studied. At 10.0 mg/ml 
NaHA, a similar effect was found in the dried samples as in the gels, while 5.0 mg/ml 
NaHA formed a more closely packed polymeric structure and could absorb more water, 
thus resulting in the increase of o-Ps lifetime values. Because the PALS method cannot 
distinguish between bound and free water, and in the course of the treatment the water 
content was not changed in hydrogels, no increase in the o-Ps lifetime values of 5.0 
mg/ml NaHA hydrogels can be seen. 
 The least variable distribution is also obtained with 7.5 mg/ml NaHA gels, and it 
indicated a supramolecular structural stability of these hydrogels after heat sterilization. 
 The viscometric studies showed that the transition point was not significantly 
changed by the heat treatment, which is in good agreement with the free volume 
distribution results. 
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 Due to the heat sterilization, the viscosity of 10.0 mg/ml NaHA hydrogel 
decreased, thus dramatically increasing the frequency of the viscoelastic transition. 
Despite the shift in the intercept, the autoclaving has no irreversible effect on the 
viscoelasticity. 
 Based on these results, the possibility of heat sterilization should not necessarily 
be excluded, but for the pharmaceutical industries it is not an optimal solution.  
 
 
5.2. Effect of the freeze-drying 
 
 The handling and working with NaHA for injections should be speeded up with 
freeze-drying. Freeze-drying has already proven as an outstanding industrial process for 
sensitive substances. These experiments were investigated to get data about the 
alterations of the structural properties of NaHA after freeze-drying. 
 The results of PALS measurements indicate that with increasing NaHA 
concentrations (5.0, 7.5 and 10.0 mg/ml) a denser polymer system can be obtained 
resulting in higher water-binding and consequent swelling ability in the course of gel 
formation. The freeze-drying process evaporated not only the physically bound water 
but ordered the supramolecular polymer structure, as well (Quinn et al., 1963). The 
latter can be confirmed with the decrease of the o-Ps lifetime values of gels obtained 
with the redissolution of the freeze-dried samples. The effect of the polymer 
concentrations on redissolved freeze-dried samples showed similar tendency to the 
original gels of corresponding concentrations without freeze-drying.  
 Support for these obtained results, 10.0 mg/ml NaHA gels were examined in 
more detail. Raw NaHA and samples prepared with water or with sodium phosphate 
buffer were used. 
 Hyaluronates have a special affinity for water. They show helical structure, 
which size is depending  on the presence of cations (sodium, potassium, calcium) and 
the packing of the double helical units is stabilized by water molecules (Sheehan et al., 
1983).  
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 However, the reconstitution of the samples with the same concentration but with 
other excipients showed very different hydration properties.  
 After freeze-drying the reconstitution test showed a great gelling ability by the 
freeze-dried NaHA gel prepared with buffer. The redissolution process was much faster 
than by the other samples without buffer.  
 The results of Lee et al. (1995) showed the importance of relative humidity of 
NaHA and the hydration degree. It indicates that the interactions are very sensitive to 
the water content. Lahajnar et Rupprecht (1986) reported also about the hydration 
similar to that of many other fibrous biopolymers at comparable relative humidity and 
the intramolecular dipolar interaction of the water molecules. 
 There are three types of water: non-freezing water, freezing-bound water and 
free water. The amount of water bonds in hyaluronates are greater than in the other 
polymers that were investigated (sodium carboxylmethyl cellulose, sodium xanthan 
etc.) (Phillips et al., 2013). 
 The viscometric studies demonstrated the effect of freeze-drying on the 
viscoelastic behaviour of NaHA and showed that the transition point remained almost 
the same. The viscoelastic curves of the freeze-dried samples strengthened that the 
supramolecular ordering did not cause functionality-related alteration in the polymer 
after gelation. NaHA retained its viscoelastic property after freeze-drying. 
 The TG measurements showed that at the temperature of 240 °C a total 
degradation of NaHA happened, which is also similar to the results obtained in the 
literature (Villetti et al., 2002; Vasi et al., 2014). 
 The results from the DSC investigations correlated with the DSC curves in the 
literature. The smaller AUC of the endothermic water peak of the thermogram also 
approved the microstructurally detected phenomenon. The DSC curves of the samples 
present a typical amorphous substance type with no interference on the chain 
conformation (Vasi et al., 2014). 
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 X-ray diffraction pattern of the samples referred to that after lyophilisation. No 
amorphous-crystalline transition of NaHA can be observed which means that the 
different rate of gelling cannot be explained by the new formation of disordered 
structure. 
 The SEM photos showed also that this disordered and elongated texture comes 
to an agreement with Harding et al. (1992). The possible explanation of this 
phenomenon could be the supramolecular interaction between the polymer chains and 
the phosphate salts. 
 The decreased o-Ps lifetime values and the consequent lower free volume holes 
confirmed the more ordered polymer structure due to the presence of phosphate salts. 
 These results are in good agreement with previous studies, which confirmed that 
HA cross-linking via phosphates could also potentially occur (Brenner et al., 2013). The 
addition of phosphate salts also facilitated the formation of ordered structure of HA that 
enabled the successful preparation of electrospun fiber mats. Similar phenomenon was 
observed in the case of interaction of phosphate salts with chitosan polymer, where 
phosphate groups increased the cross-link density and accelerated the gelation (Ruel-
Gariepy et al., 2000). The possible formation of the cross-linked network within the 
chains of hyaluronic acid in the presence of phosphates can hinder the crystal growth of 
water in the aqueous sodium hyaluronate solution in the course of the freeze-drying 
process, thus resulting in more pores with smaller average size. The latter was 
visualized on the SEM photos as ladder-like pore structure. Milosĕv et al. (2013) 
investigated HA stimulation by calcium phosphate in simulated physiological solution 
and used to analyse the composition by X-ray photoelectron spectroscopy. It is 
hypothesized that calcium promotes the cleavage of HA to smaller units, which then 
react chemically with calcium phosphate. 
 As a consequence, the highly porous structure enabled faster water absorption in 
the course of gelling to obtain redissolved NaHA. 
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 The freeze-drying is definitely a danger for the HA molecule. The biggest 
danger is the depolymerisation, which not only destroys the structure but also affects the 
solubility of the product (Wedlock et al., 1983). The raw starting HA is highly soluble 
in water and buffers. However, if the degree of the polymerization decreases, the 
solubility in water and in buffer of the obtained product decreases, too. To prevent this, 
different counterions can be used. The counterions have a protective effect for HA 
against depolymerisation. The obtained structure helps the reconstitution, too. 
 The other influencing factor of the reconstitution is the cross-linking (Chen et 
al., 2014). The cross-linking agent causes a special ordering in the molecule and 
therefore the reconstitution-ability increases. 
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6. Conclusions 
 
The supramolecular changes of NaHA hydrogels after heat sterilisation can be tracked 
using a PALS method based on the o-Ps lifetime values and distributions. The latter 
indicated the concentration dependence of the structural ordering, as interpreted by free 
volume holes. The results enabled the determination of the optimum polymer 
concentration, which allowed only reversible microstructural changes. The results were 
in good agreement with the viscoelasticity data, consequently the possibility of heat 
sterilisation should not necessarily be excluded. 
As a result of freeze-drying of NaHA supramolecular ordering was observed in the 
presence of phosphate salts and consequently highly porous structure was formed, 
which enabled fast gelling ability during reconstitution with water. The viscosity curves 
of the freeze-dried samples strengthened that the supramolecular ordering did not cause 
functionality-related alteration in the polymer after gelation. This phenomenon could be 
advantageous in the preparation of injection immediately before the application. 
 
Practical relevance of the work 
The combination of macro- and microstructural characterization of NaHA hydrogels of 
various concentrations and buffer solutions enabled both the optimization of the 
preparation process and the composition of the intra-articular injections. 
These preliminary screening examinations could contribute to the selection of the 
required type and amount of excipients as well as the technological procedures. 
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7. Summary 
 
In summary, parenteral sodium hyaluronate (NaHA) hydrogels and its structural 
changes after different treatments were investigated. In the thesis the effect of heat 
sterilization on the macro- and microstructural characteristics of various sodium 
hyaluronate gels of animal origin was evaluated. Along with the functionality-related 
characteristics (viscoelasticity, ability for reconstitution) the positron annihilation 
lifetime spectroscopy (PALS) was applied for the tracking of the microstructural 
changes of the macromolecule before and after freeze-drying of the gels.  
The combination of different testing methods enabled a comprehensive 
characterization of NaHA hydrogels. 
The obtained novel results are the followings: 
i. NaHA hydrogels have been successfully formulated with different 
concentrations for parenteral purposes with special focus on the requirements of 
the intra-articular administration. 
ii. The hydrogels after autoclaving showed partially irreversible structural 
alteration, depending on the concentration, which were confirmed by 
viscometric and PALS measurements. Consequently  the possibility of heat 
sterilization should not necessarily be excluded. 
iii. The freeze-dried hydrogels showed fast gelling ability in the presence of sodium 
phosphate salts in contrast to the freeze-dried hydrogels prepared only with 
water, which can be explained by an ordered ladder-like macroporous structure. 
The found phenomenon was responsible for the fast reconstitution, which was 
followed by the changes of the free volume holes with PALS. 
The clarification of the structural changes of different NaHA gels after heat sterilization 
and freeze drying could contribute in the determination of proper manufacturing process 
conditions in order to reserve the required functionality-related characteristics 
(viscosupplementation) of the intended dosage form.   
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8. Összefoglalás 
 
Parenterális módon alkalmazható nátrium hialuronátot tartalmazó hidrogélek 
különböző kezelések hatására végbemenő szerkezetváltozásainak feltárásával 
foglalkoztam. Állati eredetű nátrium hialuronát géleket hővel sterileztem; illetve 
fagyasztva szárításos módszerrel nátrium hialuronátot formuláltam parenterális célokra 
a makro- és mikroszerkezeti vizsgálatok eredménye alapján.  
Az injekció formulálás körülményeinek meghatározásához különböző fizikai-kémiai 
vizsgálati módszerek kombinációját alkalmaztam. 
 
Az eredményeim egyértelműen bizonyították: 
i. Különböző koncentrációjú NaHA hidrogéleket sikeresen formuláltam 
parenterális célra, kifejezetten az intraartikuláris alkalmazás szempontjait 
figyelembe véve. 
ii. A hidrogélek a hősterilezés hatására, koncentrációjuktól függően különböző 
mértékű, részben irreverzibilis szerkezetváltozást mutattak, amelyet mind a 
makro-, mind a mikroszerkezet-vizsgáló módszerek eredményei alátámasztottak. 
Következésképpen a hősterilizés lehetőségét nem szükséges minden esetben 
elvetni. 
iii. A nátrium-foszfát sókat tartalmazó hidrogélek fagyasztva szárításával kapott 
minták rendezett, létraszerű makroporózus szerkezetük következtében gyorsabb 
újragélesedést mutattak, mint a csak vízzel készültek. A gyors rekonstitúció 
hátterét makro- és mikroszerkezeti vizsgálatokkal jellemeztük. 
 
A NaHA gélek hősterilezése és fagyasztva szárítása során végbemenő szerkezeti 
változások feltárása hozzájárulhat a megfelelő gyártástechnológia kialakításához annak 
érdekében, hogy a készítmény hatékonyságának (viszkoszupplementáció) alapjául 
szolgáló funkcionális tulajdonságát biztosítsuk. 
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